Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.

Twenty-seven patients with disseminated malignant melanoma were treated monthly with cisplatin (CDDP) 120 mg m-2 on day 1, vindesine (VDS) 3 mg m-2 on day 2 and dacarbazine (DTIC) 250 mg m-2 on days 2-6. None of them had received prior chemotherapy. All patients are evaluable for response and toxici...

Descripción completa

Detalles Bibliográficos
Autores principales: Pectasides, D., Yianniotis, H., Alevizakos, N., Bafaloukos, D., Barbounis, V., Varthalitis, J., Dimitriadis, M., Athanassiou, A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247122/
https://www.ncbi.nlm.nih.gov/pubmed/2803936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247122/
https://www.ncbi.nlm.nih.gov/pubmed/2803936

Ejemplares similares